Quantitative profiling and identification of plasma proteins of spinocerebellar ataxia type 2 patients.

Swarup V, Srivastava AK, Padma MV, Moganty RR.

Neurodegener Dis. 2013;12(4):199-206. doi: 10.1159/000346585.

A multimodal evaluation of microstructural white matter damage in spinocerebellar ataxia type 3.

Guimarães RP, D'Abreu A, Yasuda CL, França MC Jr, Silva BH, Cappabianco FA, Bergo FP, Lopes-Cendes IT, Cendes F.

Mov Disord. 2013 Jul;28(8):1125-32. doi: 10.1002/mds.25451.

Mimicking capacity of spinocerebellar ataxia type 3: the details matter."

Bettencourt C, Lima M.

J Neurol Sci. 2013 Mar 15;326(1-2):120-1; author reply 122. doi: 10.1016/j.jns.2013.01.022. No abstract available.

Assessing the efficacy of specific cerebellomodulatory drugs for use as therapy for spinocerebellar ataxia type 1.

Nag N, Tarlac V, Storey E.

Cerebellum. 2013 Feb;12(1):74-82. doi: 10.1007/s12311-012-0399-x.

Retinal segmentation as noninvasive technique to demonstrate hyperplasia in ataxia of Charlevoix-Saguenay.

Garcia-Martin E, Pablo LE, Gazulla J, Vela A, Larrosa JM, Polo V, Marques ML, Alfaro J.

Invest Ophthalmol Vis Sci. 2013 Oct 29;54(10):7137-42. doi: 10.1167/iovs.13-12726.

Erythropoietin in Friedreich ataxia.

Mariotti C, Nachbauer W, Panzeri M, Poewe W, Taroni F, Boesch S.

J Neurochem. 2013 Aug;126 Suppl 1:80-7. doi: 10.1111/jnc.12301. Review.

Polyglutamine disease toxicity is regulated by Nemo-like kinase in spinocerebellar ataxia type 1.

Ju H, Kokubu H, Todd TW, Kahle JJ, Kim S, Richman R, Chirala K, Orr HT, Zoghbi HY, Lim J.

J Neurosci. 2013 May 29;33(22):9328-36. doi: 10.1523/JNEUROSCI.3465-12.2013.

The ataxia telangiectasia mutated kinase controls Igκ allelic exclusion by inhibiting secondary Vκ-to-Jκ rearrangements.

Steinel NC, Lee BS, Tubbs AT, Bednarski JJ, Schulte E, Yang-Iott KS, Schatz DG, Sleckman BP, Bassing CH.

J Exp Med. 2013 Feb 11;210(2):233-9. doi: 10.1084/jem.20121605.

[Weight loss, dementia and ataxia susceptible to doxycycline: a likely new case report caused by T. whipplei].

Lagier JC, Fenollar F, Koric L, Guedj E, Ceccaldi M, Raoult D.

Rev Med Interne. 2013 Oct;34(10):641-4. doi: 10.1016/j.revmed.2012.12.006. French.

Marked improvement in opsoclonus and cerebellar ataxia after the surgical removal of a squamous cell carcinoma of the thymus: a case report.

Yamaguchi Y, Wada M, Tanji H, Kurokawa K, Kawanami T, Ohtake H, Kato T.

J Neurol Sci. 2013 Feb 15;325(1-2):156-9. doi: 10.1016/j.jns.2012.11.011.

Development of frataxin gene expression measures for the evaluation of experimental treatments in Friedreich's ataxia.

Plasterer HL, Deutsch EC, Belmonte M, Egan E, Lynch DR, Rusche JR.

PLoS One. 2013 May 17;8(5):e63958. doi: 10.1371/journal.pone.0063958.

A 19-year-old male with cerebellar ataxia and cognitive impairment following glandular fever.

Wise FM, Olver J, Infeld B.

J Clin Neurosci. 2013 May;20(5):749-50. doi: 10.1016/j.jocn.2012.03.052.

Mitochondrial dysfunction in a novel form of autosomal recessive ataxia.

Murad NA, Cullen JK, McKenzie M, Ryan MT, Thorburn D, Gueven N, Kobayashi J, Birrell G, Yang J, Dörk T, Becherel O, Grattan-Smith P, Lavin MF.

Mitochondrion. 2013 May;13(3):235-45. doi: 10.1016/j.mito.2012.11.006. Review.

Spinocerebellar ataxia type 10: from Amerindians to Latin Americans.

Teive HA, Ashizawa T.

Curr Neurol Neurosci Rep. 2013 Nov;13(11):393. doi: 10.1007/s11910-013-0393-9. No abstract available.

Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome.

Hagerman R, Hagerman P.

Lancet Neurol. 2013 Aug;12(8):786-98. doi: 10.1016/S1474-4422(13)70125-X. Review.